This series of articles will provide you with an update on tax developments that impact organisations in Ireland and those that do business with Ireland.
The buzz word which predominated the international tax landscape in 2015 was BEPS. In 2016 it is likely to be relegated to second place and superseded by CCCTB.
Much and all as we may trot out the politically correct response to the proposed lowering of the corporation tax rate in Northern Ireland it is not, in reality, going to be really good news for the Republic of Ireland.
By Paul Mee, Tax Partner, Mazars
Employers are always looking for different ways to incentivise and reward employees tax efficiently. After all, simple salary increases and bonuses both attract income tax, PRSI and USC for the employee and employer’s PRSI.
Mazars has a track record of providing a first-class detailed and tailored service that goes beyond the regular requirements of an R&D tax credit review.
At a time of very high marginal tax rates applying to the salaries and benefits provided to employees, payments that can be made on a tax free basis for the employee, and carrying the advantage of a tax deduction for the employer, should be very attractive to both the employee and the employer.
With the increased globalisation of business and with Irish businesses looking to develop growth opportunities overseas, this involves employees working more in other countries.
Gerry Vahey offers an overview of the medical-device sector in Ireland and internationally, along with the benefits of R&D tax credits and the Knowledge Development Box for Irish-based companies.
Before you look to sell an asset, are you aware of the tax consequences of same? This tax takes the form of Capital Gains Tax (CGT), and is broadly payable on gains that are made on the sale of assets.
Mazars tax experts address R&D tax credits and the Knowledge Development Box for the Irish digital technology sector.